Elizabeth K. Seng

Elizabeth K. Seng

Auto-generated profile, based on publicly available information

Elizabeth K. Seng

Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, United States

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2022 in The Lancet Neurology
Verified
Journal Article
Closed access
ESElizabeth K Seng
Elizabeth K Seng
PMPaul R Martin
Paul R Martin
THTimothy T Houle
Timothy T Houle

1 November 2017 in Current Pain and Headache Reports
Verified
Journal Article
Closed access
PDF file
ZPZarine S. Patel
Zarine S. Patel
LHLauren K. Hoffman
Lauren K. Hoffman
DBDawn C. Buse
Dawn C. Buse
AGAmy S. Grinberg
Amy S. Grinberg
LALadan Afifi
Ladan Afifi
ESElizabeth K. Seng
Elizabeth K. Seng

31 January 2017 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Closed access
PDF file
ESElizabeth K. Seng
Elizabeth K. Seng
DBDawn C. Buse
Dawn C. Buse
JKJaclyn E. Klepper
Jaclyn E. Klepper
SMSarah J. Mayson Ma
Sarah J. Mayson Ma
AGAmy S. Grinberg
Amy S. Grinberg
RLRichard B. Lipton
Richard B. Lipton

26 September 2019 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Closed access
PDF file
ESElizabeth K. Seng
Elizabeth K. Seng
ASAlexandra B. Singer
Alexandra B. Singer
CMChristopher Metts
Christopher Metts
AGAmy S. Grinberg
Amy S. Grinberg
ZPZarine S. Patel
Zarine S. Patel
DBDawn C. Buse
Dawn C. Buse

13 February 2024 in Neurology
Verified
Journal Article
Open access
RSRobert E. Shapiro
Robert E. Shapiro
RNRobert A. Nicholson
Robert A. Nicholson
ESElizabeth K. Seng
Elizabeth K. Seng
DBDawn C. Buse
Dawn C. Buse
MRMichael L. Reed
Michael L. Reed
RLRichard B. Lipton
Richard B. Lipton
This population-based analysis characterizes the relative frequency of migraine-related stigma and its cross-sectional relationship to migraine outcomes. We hypothesized that migraine-related stigma would be inversely associated with favorable migraine outcomes across headache day categories. OVERCOME (US) is a web-based observational study that annually recruited a demographically representative US sample and then identified people with active migraine using a validated migraine diagnostic questionnaire. It also assessed how frequently respondents experienced migraine-related stigma using a novel 12-item questionnaire (Migraine-Related Stigma, MiRS) that contained 2 factors; feeling that others viewed migraine as being used for Secondary Gain (8 items, α = 0.92) and feeling that others were Minimizing disease Burden (4 items, α = 0.86). We defined 5 groups: (1) MiRS-Both (Secondary Gain and Minimizing Burden often/very often; (2) MiRS-SG (Secondary Gain often/very often); (3) MiRS-MB (Minimizing Burden often/very often); (4) MiRS-Rarely/Sometimes; (5) MiRS-Never. Using MiRS group as the independent variable, we modeled its cross-sectional relationship to disability (Migraine Disability Assessment, MIDAS), interictal burden (Migraine Interictal Burden Scale-4), and migraine-specific quality of life (Migraine Specific Quality of Life v2.1 Role Function-Restrictive) while controlling for sociodemographics, clinical features, and monthly headache day categories. Among this population-based sample with active migraine (n = 59,001), mean age was 41.3 years and respondents predominantly identified as female (74.9%) and as White (70.1%). Among respondents, 41.1% reported experiencing, on average, ≥4 monthly headache days and 31.7% experienced migraine-related stigma often/very often; the proportion experiencing migraine-related stigma often/very often increased from 25.5% among those with <4 monthly headache days to 47.5% among those with ≥15 monthly headache days. The risk for increased disability (MIDAS score) was significant for each MiRS group compared with the MiRS-Never group; the risk more than doubled for the MiRS-Both group (rate ratio 2.68, 95% CI 2.56-2.80). For disability, interictal burden, and migraine-specific quality of life, increased migraine-related stigma was associated with increased disease burden across all monthly headache day categories. OVERCOME (US) found that 31.7% of people with migraine experienced migraine-related stigma often/very often and was associated with more disability, greater interictal burden, and reduced quality of life.

3 June 2021 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Open access
PDF file
PEPaige M. Estave
Paige M. Estave
SBSummerlyn Beeghly
Summerlyn Beeghly
RAReid Anderson
Reid Anderson
CMCaitlyn Margol
Caitlyn Margol
MSMariam Shakir
Mariam Shakir
RWRebecca Erwin Wells
Rebecca Erwin Wells
Objective: To better characterize the ways that migraine affects multiple domains of life. Background: Further understanding of migraine burden is needed. Methods: Adults with migraine randomized to mindfulness‐based stress reduction or headache education arms ( n = 81) in two separate randomized clinical trials participated in semistructured in‐person qualitative interviews conducted after the interventions. Interviews queried participants on migraine impact on life and were audio‐recorded, transcribed, and summarized into a framework matrix. A master codebook was created until meaning saturation was reached and magnitude coding established code frequency. Themes and subthemes were identified using a constructivist grounded theory approach. Results: Despite most participants being treated with acute and/or prophylactic medications, 90% (73/81) reported migraine had a negative impact on overall life, with 68% (55/81) endorsing specific domains of life impacted and 52% (42/81) describing impact on emotional health. Six main themes of migraine impact emerged: (1) global negative impact on overall life; (2) impact on emotional health; (3) impact on cognitive function; (4) impact on specific domains of life (work/career, family, social); (5) fear and avoidance (pain catastrophizing and anticipatory anxiety); and (6) internalized and externalized stigma. Participants reported how migraine (a) controls life, (b) makes life difficult, and (c) causes disability during attacks, with participants (d) experiencing a lack of control and/or (e) attempting to push through despite migraine. Emotional health was affected through (a) isolation, (b) anxiety, (c) frustration/anger, (d) guilt, (e) mood changes/irritability, and (f) depression/hopelessness. Cognitive function was affected through concentration and communication difficulties. Conclusions: Migraine has a global negative impact on overall life, cognitive and emotional health, work, family, and social life. Migraine contributes to isolation, frustration, guilt, fear, avoidance behavior, and stigma. A greater understanding of the deep burden of this chronic neurological disease is needed to effectively target and treat what is most important to those living with migraine.